{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:54:47Z","timestamp":1649048087109},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.eururo.2017.09.014","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T14:15:59Z","timestamp":1506608159000},"page":"233-235","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fewer Recurrences with Immediate versus Delayed Intravesical Mitomycin C: A Prospective Randomized European Trial"],"prefix":"10.1016","volume":"73","author":[{"given":"Shandra S.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. David","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2017.09.014_bib0055","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guidelines for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.09.014_bib0060","unstructured":"National Comprehensive Cancer Network. Clinical practice guidelines in oncology: bladder cancer. www.nccn.org\/professionals\/physician_gls\/PDF\/bladder.pdf."},{"key":"10.1016\/j.eururo.2017.09.014_bib0065","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.urology.2009.12.070","article-title":"Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system","volume":"76","author":"Feifer","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2017.09.014_bib0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eururo.2017.06.038","article-title":"Value of an immediate intravesical instillation of mitomycin C in patients with non\u2013muscle-invasive bladder cancer: a prospective multicenter randomized study in 2243 patients","volume":"73","author":"Bosschieter","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.09.014_bib0075","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(11)70190-5","article-title":"Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial","volume":"12","author":"Di Stasi","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2017.09.014_bib0080","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1097-0142(19800901)46:5<1158::AID-CNCR2820460514>3.0.CO;2-E","article-title":"Urothelial susceptibility to tumor cell implantation: influence of cauterization","volume":"46","author":"Soloway","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.09.014_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2006.08.070","article-title":"Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?","volume":"177","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.09.014_bib0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2007.03.028","article-title":"A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patient with bladder cancer: a phase III, multicenter study","volume":"178","author":"Fradet","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.09.014_bib0095","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/cncr.25521","article-title":"Fluorescence cystoscopy for nonmuscle invasive bladder cancer: is the honeymoon over for the blue light special?","volume":"117","author":"Shah","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.09.014_bib0100","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/s41598-017-03421-5","article-title":"Systematic review and cumulative analysis of the combination of mitomycin C plus bacillus Calmette-Guerin (BCG) for non-muscle-invasive bladder cancer","volume":"7","author":"Deng","year":"2017","journal-title":"Sci Rep"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817307789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817307789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T07:24:12Z","timestamp":1535354652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283817307789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0302283817307789"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2017.09.014","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fewer Recurrences with Immediate versus Delayed Intravesical Mitomycin C: A Prospective Randomized European Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.06.038","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}